iStent infinite®
The iStent infinite® Trabecular Micro-Bypass System Model iS3 is an implantable device intended to reduce the intraocular pressure (IOP) of the eye. It is indicated for use in adult patients with primary open-angle glaucoma in whom previous medical and surgical treatment has failed.
iStent infinite® is the first micro-invasive standalone implantable alternative.
Key Advantages
Optimized Outflow
Two multi-directional stents designed to restore natural outflow
Clinically Proven
Significant IOP reduction across a wide range of clinical studies 1 2
Procedural Elegance
Predictability and precision meet the needs of your practice
Proven Safety
Safety profile similar to cataract surgery alone
Can be Used in Patients Undergoing Cataract Surgery or a Standalone Procedure
iStent infinite® gives you the versatility to treat a variety of patients who have failed prior medical and surgical intervention, when combined with cataract surgery or in a standalone surgical setting.
The Beginning of the Interventional Glaucoma Revolution
With 3 anatomically designed stents preloaded into an elegant injector system, iStent infinite® is a first-of-its-kind, standalone implantable alternative designed to:
- Provide powerful technology to deliver foundational, 24/7, long-term control of IOP in patients with glaucoma who have failed prior medical and surgical intervention1
- Safely offer interventional glaucoma, a truly micro-invasive alternative to medications and more invasive procedures, helping address rampant rates of patient non-compliance and disease progression
- Restore physiologic outflow by creating arcs of flow spanning up to 8 clock hours (240°) while minimizing tissue disruption—broad coverage vs other MIGS procedures1
- Provide you the versatility to treat a variety of patients
Go With the Flow—Rejuvenate the System
iStent infinite® is designed to maximize outflow while minimizing disruption to natural anatomy by occupying only 3% of Schlemm’s canal, thereby leaving 97% untouched.
This, coupled with a patented multidirectional stent design, helps bypass resistance and restore physiologic outflow.
Intermediate Therapy That Excels Where Other Treatments Have Failed
In the prospective, multicenter, 12-month pivotal trial, patients with open-angle glaucoma who had failed prior surgical intervention underwent standalone iStent infinite® implantation1.
Despite this tough-to-treat population, iStent infinite® delivered exceptional results demonstrating sustained efficacy throughout the course of the study, as well as exceptional intraoperative and postoperative safety1.
Elegantly Precise Microsurgery
An elegant, precision-engineered injector system allows you to implant 3 wide-flange, anatomically designed stents across 180° of Schlemm’s canal.
Explore Patient Resources for Glaucoma Treatment Options
iStent infinite® is indicated for use in adult patients with primary open-angle glaucoma in whom previous medical and surgical treatment has failed. Through this procedure, you may be able to provide your patients with better IOP control and a reduced dependence on medication.
Our Gallery
